Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) EBITDA (2020 - 2025)

Historic EBITDA for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to -$23.1 million.

  • Celularity's EBITDA fell 4331.06% to -$23.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.6 million, marking a year-over-year decrease of 11534.62%. This contributed to the annual value of -$57.9 million for FY2024, which is 7048.32% up from last year.
  • Celularity's EBITDA amounted to -$23.1 million in Q3 2025, which was down 4331.06% from -$24.5 million recorded in Q2 2025.
  • In the past 5 years, Celularity's EBITDA registered a high of $49.9 million during Q3 2021, and its lowest value of -$93.9 million during Q3 2023.
  • In the last 5 years, Celularity's EBITDA had a median value of -$19.7 million in 2025 and averaged -$19.3 million.
  • Data for Celularity's EBITDA shows a peak YoY increase of 113907.62% (in 2021) and a maximum YoY decrease of 2900729.81% (in 2021) over the last 5 years.
  • Celularity's EBITDA (Quarter) stood at -$4.0 million in 2021, then soared by 699.18% to $24.2 million in 2022, then crashed by 70.45% to $7.2 million in 2023, then tumbled by 285.91% to -$13.3 million in 2024, then plummeted by 73.53% to -$23.1 million in 2025.
  • Its EBITDA was -$23.1 million in Q3 2025, compared to -$24.5 million in Q2 2025 and -$19.7 million in Q1 2025.